Upcoming Seminar: Beyond ‘good enough’: How to engage communities with COVID-19 research quickly and effectively

Response to COVID-19 requires rapid research to develop vaccines, treatments and other kinds of urgently needed knowledge. Previous public health emergencies have demonstrated that good community engagement helps move research forward, ensures it is feasible, relevant, and accepted, and that its findings are taken up. But how can it be done quickly, and in the midst of lockdowns? On this webinar we will explore these questions, and hear from the experts how to bring Good Participatory Practices to COVID-19 research.

Chair: Lisa Schwartz, McMaster University

Panelists: 
John Marshall – University of Toronto 
Noni Mumba – KEMRI-Wellcome Trust Research Programme, Kenya 
Phaikyeong Cheah – Oxford University, Wellcome Programme, Thailand 
Alun Davies – KEMRI-Wellcome Trust Research Programme, Kenya

15 June 2020 | 1-2 pm GMT+1 | Full poster hereRegister via Zoom

Please note that this seminar is limited to 500 participants. The seminar will be live streamed to The Global Health Network's Facebook page and the recording will be available in the following days. 

*   Most recent seminars   *


Digital Technologies and their Ethical Application during the COVID-19 Pandemic

01 June 2020

Digital technologies, including those that utilize artificial intelligence, are increasingly being used to aid COVID-19 surveillance and response efforts. While these digital technologies, such as digital proximity tracking technologies, will undoubtedly play an important role, their use raises important ethical and governance concerns. This webinar will discuss the use of digital technologies, the ethical and human rights implications of their use, and possible ways forward in implementing such technologies in a manner that upholds and promotes key ethical norms.



Click here to view this seminar in full screen. 



Click here to view this seminar in full screen. 

 

COVID-19 Human Challenge Studies: Is it OK for research participants to volunteer to be infected?

18 May 2020

As widespread use of safe and efficacious vaccines for COVID-19 could save many lives and enable governments to ease restrictive control measures, there is an urgent ethical imperative for well-designed and carefully conducted research to develop such vaccines and increase relevant scientific knowledge regarding SARS-CoV-2. Controlled human infection studies, also known as human challenge studies, have been proposed as one means of testing the many vaccine candidates for SARS-CoV-2. While this has attracted considerable attention with wide calls for COVID-19 challenge studies, the research community is divided over their ethical acceptability.


COVID-19 Immunity Passports: Inevitable? Ethical?

04 May 2020

Assuming that recovery from COVID-19 brings a measure of immunity, some have proposed that the detection of antibodies to the SARS-CoV-2 virus could serve as the basis for an ‘immunity passport’ that would enable individuals to travel or to return to work. While health officials and scientists continue to review the evidence on antibody responses to SARS-CoV-2 infection, critical ethical questions related to stigma, health inequities, and the evidential basis for the use of immunity passports must be addressed.



Click here to view this seminar in full screen. 



Click here to view this seminar in full screen. 


Why should ethics be front and centre to the response to COVID-19. Is it?

20 April 2020

This is the first online seminar from PHEPREN (Public Health Emergency Preparedness and Response Ethics Network), the newly launched global community of bioethicists, established to provide real-time, trusted, contextual support to communities, policy makers, researchers, and responders in relation to the ethical issues arising out of global health emergencies.